Please use this identifier to cite or link to this item:
https://scholarbank.nus.edu.sg/handle/10635/235015
Title: | BIOLOGICAL INSIGHTS INTO CORONARY HEART DISEASE VIA OMICS BEYOND THE CENTRAL DOGMA | Authors: | LIM SI YING | ORCID iD: | ![]() |
Keywords: | coronary heart disease, multi-omics, metabolomics, lipidomics, glycomics, metallomics | Issue Date: | 5-Jul-2022 | Citation: | LIM SI YING (2022-07-05). BIOLOGICAL INSIGHTS INTO CORONARY HEART DISEASE VIA OMICS BEYOND THE CENTRAL DOGMA. ScholarBank@NUS Repository. | Abstract: | Despite remarkable progress in disease diagnosis and treatment, coronary heart disease (CHD) remains the number one leading cause of death worldwide. Novel and reliable biomarkers are needed to assist in risk assessment, accurate diagnosis and prognosis, and may also act as mediators of disease. For this reason, this multidisciplinary research aims to investigate the translational potential of omics beyond the central dogma (OBCD; comprising metabolomics, lipidomics, glycomics, and metallomics) for CHD. Novel insights into the underlying biological pathways could also be added to the overall omics information trove and advance our understanding of this disease. Hence, this thesis delivers an ensemble of five projects with three overarching phases: (1) a bibliometric study and literature review for the identification of research trends and knowledge gaps in CHD-OBCD, (2) a set of two independent studies and one multi-omics investigation, and (3) novel analytical method development of a bi-omics extraction and analysis workflow. | URI: | https://scholarbank.nus.edu.sg/handle/10635/235015 |
Appears in Collections: | Ph.D Theses (Restricted) |
Show full item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
LimSY_Thesis.pdf | 6.73 MB | Adobe PDF | RESTRICTED | None | Log In |
Page view(s)
10
checked on Jan 26, 2023
Download(s)
1
checked on Jan 26, 2023
Google ScholarTM
Check
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.